Get 5% off Cloud-Clone’s cancer biomarker ELISA kits until 31st December 2024! Contact us with promo code ‘CLOUD5Q3’ to redeem this offer.
VivoVist™ – The Ultimate X-ray Contrast Agent for Micro CT
VivoVist™ is a revolutionary nanotechnology super contrast agent of alkaline earth metal nanoparticles for enhanced X-ray imaging in microCT.
Cervical cancer is the fourth most common cancer affecting women: Antigen-Specific Detection of HPV and HSV
Cervical cancer is the 4th most prevalent cancer among women, and the 7th most common cancer. MBLI provides HPV-related tetramers for use in research.
Rapid and Reliable Custom Tetramer Generation for T-Cell Staining
MBLI QuickSwitch™ kit technology aims to replicate the immune response by mimicking peptide exchange on an MHC molecule.
Advancements in the understanding of m7G Modification
There is more data that highlights the significant role of m7G modification in human diseases, particularly cancer.
The Impact of In Vivo Isotype Controls on Therapeutic Drug Development
In vivo antibody studies offer a wide range of applications. Discover the significant impact of antibody selection on your experiment.
Explore the Limitless Potential of IL-18
Researchers take advantage of MBL International’s recombinant IL-18 to activate varying cells like peripheral blood cells, macrophages, NK cells and T cells to identify targets.
Bispecific T-Cell Engaging (BiTE) Antibodies: A Promising Cancer Therapy
Krishgen is the only manufacturer of ELISA for pharmacokinetic studies of BsAbs, with 40+ drug targets in a sensitive, highly specific ELISA format.
Chimeric Antigen Receptor (CAR) T Cell Therapy
Chimeric Antigen Receptor (CAR) T cell therapy is a revolutionary approach in the field of cancer immunotherapy.
Cancer Immunotherapy: An increasing emphasis on CD4+ T cells and MHC Class II Neoantigens
QuickSwitch™ Class II Tetramer Peptide Exchange and Quantitation Kit utilises a patented technique for exchanging up to ten peptides on an MHC Class II Tetramer.